» Articles » PMID: 35782410

From Underground to Mainstream: Establishing a Medical Lexicon for Psychedelic Therapy

Overview
Specialty Psychiatry
Date 2022 Jul 5
PMID 35782410
Authors
Affiliations
Soon will be listed here.
Abstract

We argue that non-stigmatizing and precise terminology grounded in the medical model will advance both the science and public acceptance of psychedelics. Researchers and clinicians should take care to distinguish between medical, recreational, and spiritual uses to set clear boundaries and expectations for patients. Ethically fraught or stigmatizing terms should be replaced with terminology that is medically and scientifically descriptive and accurate. A medicalized linguistic framework around psychedelics will potentially yield benefits and mitigate risks. Replacing colloquial names with scientific names for medicines and therapies may help correct misconceptions about psychedelics commonly held by both professionals and the public. A harmonized medical lexicon will also provide a common language for important instances of communication-such as the informed consent process-between professionals and participants. Our recommendations draw upon communications research in addiction medicine and aim to encourage the development, acceptance, and implementation of non-stigmatizing terminology in psychedelic research and treatment.

Citing Articles

Efficacy of intraoperative subanesthetic dose of ketamine/esketamine in preventing postoperative cognitive dysfunction: a systematic review and meta-analysis.

Zhou N, Chen C, Liu Y, Yu Z, Chen Y Ther Adv Psychopharmacol. 2023; 13:20451253231200261.

PMID: 37915364 PMC: 10617260. DOI: 10.1177/20451253231200261.

References
1.
Messamore E, Dugan S . Informed Consent: A Policy Prescription for Communicating Benefit and Risk in State Medical Marijuana Programs. Psychiatr Serv. 2020; 71(9):941-946. DOI: 10.1176/appi.ps.202000140. View

2.
Corrigan P, Rao D . On the self-stigma of mental illness: stages, disclosure, and strategies for change. Can J Psychiatry. 2012; 57(8):464-9. PMC: 3610943. DOI: 10.1177/070674371205700804. View

3.
Tsai A, Kiang M, Barnett M, Beletsky L, Keyes K, McGinty E . Stigma as a fundamental hindrance to the United States opioid overdose crisis response. PLoS Med. 2019; 16(11):e1002969. PMC: 6957118. DOI: 10.1371/journal.pmed.1002969. View

4.
Murphy J, Franz B . Ethics in Narrative Health Interventions. Perm J. 2019; 24. PMC: 6844548. DOI: 10.7812/TPP/19.029. View

5.
Hatzenbuehler M, Phelan J, Link B . Stigma as a fundamental cause of population health inequalities. Am J Public Health. 2013; 103(5):813-21. PMC: 3682466. DOI: 10.2105/AJPH.2012.301069. View